Patrick J. McEnany, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 400,000 shares at $26.11 ($10.4M) on 2025-06-09, disclosed to the SEC on 2025-06-10.
Open-market sale of $10.4M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.95 | 28,252 | $733K | 7.0% |
| 2 | $25.95 | 28,252 | $733K | 7.0% |
| 3 | $26.11 | 171,748 | $4.5M | 43.0% |
| 4 | $26.11 | 171,748 | $4.5M | 43.0% |
| Total | $26.09 avg | 400,000 | $10.4M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |
| CPRX | SELL | 2022-11-22 | $7.8M | — | Filing → |